Success Metrics

Clinical Success Rate
97.3%

Based on 36 completed trials

Completion Rate
97%(36/37)
Active Trials
24(28%)
Results Posted
31%(11 trials)
Terminated
1(1%)

Phase Distribution

Ph phase_2
3
3%
Ph phase_4
1
1%
Ph early_phase_1
4
5%
Ph not_applicable
64
74%
Ph phase_1
9
10%

Phase Distribution

13

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution81 total trials
Early Phase 1First-in-human
4(4.9%)
Phase 1Safety & dosage
9(11.1%)
Phase 2Efficacy & side effects
3(3.7%)
Phase 4Post-market surveillance
1(1.2%)
N/ANon-phased studies
64(79.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.7%

36 of 43 finished

Non-Completion Rate

16.3%

7 ended early

Currently Active

24

trials recruiting

Total Trials

86

all time

Status Distribution
Active(34)
Completed(36)
Terminated(7)
Other(9)

Detailed Status

Completed36
Recruiting21
Not yet recruiting9
unknown9
Withdrawn6
Active, not recruiting3

Development Timeline

Analytics

Development Status

Total Trials
86
Active
24
Success Rate
97.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (4.9%)
Phase 19 (11.1%)
Phase 23 (3.7%)
Phase 41 (1.2%)
N/A64 (79.0%)

Trials by Status

terminated11%
withdrawn67%
completed3642%
not_yet_recruiting910%
recruiting2124%
unknown910%
enrolling_by_invitation11%
active_not_recruiting33%

Recent Activity

Clinical Trials (86)

Showing 20 of 86 trialsScroll for more
NCT00453505Early Phase 1

Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System

Completed
NCT07547319Not Applicable

Effects of Accelerated rTMS on Cognitive Function

Recruiting
NCT03351764Not Applicable

Development of Non-Invasive Brain Stimulation Techniques

Completed
NCT02363296Not Applicable

Main Study: Influence on Plasticity of Brain Temperature Sub-Study: Phase Triggered Paired Associative Stimulation (PAS)

Completed
NCT07680140Phase 4

Biomarker-Guided Antidepressant Selection

Not Yet Recruiting
NCT07570212Not Applicable

Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders

Recruiting
NCT07147218Not Applicable

Accelerated TMS for MDD

Active Not Recruiting
NCT06548113Not Applicable

Sensory Synchronized Imaging and Neuromodulation

Not Yet Recruiting
NCT06824415Not Applicable

Sleep TMS for Depression

Recruiting
NCT07554833Not Applicable

Effects of Accelerated rTMS On Motor and Cognitive Function in Parkinson's Disease

Recruiting
NCT07636694Not Applicable

Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)

Recruiting
NCT04179435Not Applicable

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

Completed
NCT07460947Phase 1

A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder

Recruiting
NCT07488429Not Applicable

Impact of rTMS Combined With Neurorehabilitation on Lower Extremity Motor Function and Spasticity in Children With Spastic Diplegic Cerebral Palsy

Recruiting
NCT06945731Not Applicable

The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Weight Loss in Overweight and Obese Patients

Completed
NCT07595185Not Applicable

Effects of Accelerated rTMS on Sleep Architecture in Chronic Insomnia Disorder

Not Yet Recruiting
NCT07593222Phase 1

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

Not Yet Recruiting
NCT06876129Phase 1

Pharmacologic Augmentation of TMS for Depression With D-serine

Recruiting
NCT07574164Not Applicable

Closed-loop TMS for Tremor

Recruiting
NCT06696365Not Applicable

iTBS for Alcohol Use Disorder

Terminated

Drug Details

Intervention Type
DEVICE
Total Trials
86